Kenji Kozuka

1.1k total citations
12 papers, 587 citations indexed

About

Kenji Kozuka is a scholar working on Molecular Biology, Gastroenterology and Nephrology. According to data from OpenAlex, Kenji Kozuka has authored 12 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Gastroenterology and 4 papers in Nephrology. Recurrent topics in Kenji Kozuka's work include Gastrointestinal motility and disorders (4 papers), Ion Transport and Channel Regulation (4 papers) and Magnesium in Health and Disease (3 papers). Kenji Kozuka is often cited by papers focused on Gastrointestinal motility and disorders (4 papers), Ion Transport and Channel Regulation (4 papers) and Magnesium in Health and Disease (3 papers). Kenji Kozuka collaborates with scholars based in United States and Sweden. Kenji Kozuka's co-authors include Andrew Spencer, Dominique Charmot, Limin He, Samantha Koo-McCoy, Michael R. Leadbetter, Matthew Siegel, Jill Kohler, Eric D. Labonté, Noah Bell and Jeffrey Jacobs and has published in prestigious journals such as Molecular and Cellular Biology, Journal of Medicinal Chemistry and Journal of the American Society of Nephrology.

In The Last Decade

Kenji Kozuka

12 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Kozuka United States 9 227 149 122 110 105 12 587
Limin He China 5 139 0.6× 56 0.4× 95 0.8× 98 0.9× 90 0.9× 6 390
Michiko Yamashita Japan 11 129 0.6× 22 0.1× 124 1.0× 38 0.3× 31 0.3× 27 500
May Wong Australia 12 191 0.8× 27 0.2× 19 0.2× 33 0.3× 30 0.3× 24 406
John Sterpka United States 7 254 1.1× 22 0.1× 58 0.5× 186 1.7× 110 1.0× 8 551
Philip G. Holtzapple United States 16 140 0.6× 45 0.3× 50 0.4× 16 0.1× 52 0.5× 43 641
Italia Loddo Italy 8 147 0.6× 35 0.2× 27 0.2× 15 0.1× 32 0.3× 11 438
Yasuyuki Nakae Japan 12 39 0.2× 39 0.3× 28 0.2× 17 0.2× 104 1.0× 47 435
Hisatsugu Noda Japan 9 147 0.6× 127 0.9× 24 0.2× 11 0.1× 27 0.3× 20 391
José Duarte Spain 12 195 0.9× 18 0.1× 17 0.1× 15 0.1× 61 0.6× 17 466
Peter Suenaert Sweden 11 230 1.0× 87 0.6× 38 0.3× 3 0.0× 112 1.1× 19 611

Countries citing papers authored by Kenji Kozuka

Since Specialization
Citations

This map shows the geographic impact of Kenji Kozuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Kozuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Kozuka more than expected).

Fields of papers citing papers by Kenji Kozuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Kozuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Kozuka. The network helps show where Kenji Kozuka may publish in the future.

Co-authorship network of co-authors of Kenji Kozuka

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Kozuka. A scholar is included among the top collaborators of Kenji Kozuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Kozuka. Kenji Kozuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lacy, Brian E., et al.. (2024). Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3). Clinical and Experimental Gastroenterology. Volume 17. 173–183. 2 indexed citations
2.
Singh, Prashant, et al.. (2024). An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation. Clinical and Experimental Gastroenterology. Volume 17. 87–96. 4 indexed citations
3.
King, Andrew J., Lin Chang, Qian Li, et al.. (2024). NHE3 inhibitor tenapanor maintains intestinal barrier function, decreases visceral hypersensitivity, and attenuates TRPV1 signaling in colonic sensory neurons. American Journal of Physiology-Gastrointestinal and Liver Physiology. 326(5). G543–G554. 11 indexed citations
4.
Gallant, Kathleen M. Hill, Stuart M. Sprague, David P. Rosenbaum, et al.. (2024). Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients With Kidney Failure. Journal of Renal Nutrition. 35(1). 25–34. 3 indexed citations
5.
Jacobs, Jeffrey, Michael R. Leadbetter, Noah Bell, et al.. (2022). Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na+/H+ Exchanger Isoform 3. ACS Medicinal Chemistry Letters. 13(7). 1043–1051. 14 indexed citations
6.
Chen, Tao, Noah Bell, Patricia D. Finn, et al.. (2018). Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5). Journal of Medicinal Chemistry. 61(17). 7589–7613. 28 indexed citations
7.
Kozuka, Kenji, Ying He, Samantha Koo-McCoy, et al.. (2017). Development and Characterization of a Human and Mouse Intestinal Epithelial Cell Monolayer Platform. Stem Cell Reports. 9(6). 1976–1990. 132 indexed citations
8.
Johansson, Susanne, Maria Leonsson‐Zachrisson, Mikael Knutsson, et al.. (2016). Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders. Clinical Pharmacology in Drug Development. 6(5). 448–456. 16 indexed citations
9.
Labonté, Eric D., Christopher W. Carreras, Michael R. Leadbetter, et al.. (2014). Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD. Journal of the American Society of Nephrology. 26(5). 1138–1149. 86 indexed citations
10.
Spencer, Andrew, Eric D. Labonté, David P. Rosenbaum, et al.. (2014). Intestinal Inhibition of the Na + /H + Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na + Uptake in Humans. Science Translational Medicine. 6(227). 227ra36–227ra36. 126 indexed citations
11.
Siegel, Matthew, Mitchell Garber, Andrew Spencer, et al.. (2011). Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials. Digestive Diseases and Sciences. 57(2). 440–450. 78 indexed citations
12.
Guelman, Sebastián, Kenji Kozuka, Yifan Mao, et al.. (2008). The Double-Histone-Acetyltransferase Complex ATAC Is Essential for Mammalian Development. Molecular and Cellular Biology. 29(5). 1176–1188. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026